Ellevest, Inc. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ellevest, Inc. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,0000.0%100
+177.8%
0.00%
Q1 2022$1,0000.0%36
-29.4%
0.00%
Q4 2021$1,000
-66.7%
51
-63.0%
0.00%
Q3 2021$3,000
+50.0%
138
+46.8%
0.00%
Q2 2021$2,0000.0%94
+70.9%
0.00%
Q1 2021$2,000
-33.3%
550.0%0.00%
Q4 2020$3,000
+200.0%
55
+22.2%
0.00%
Q3 2020$1,0000.0%45
+66.7%
0.00%
Q2 2020$1,0000.0%27
-22.9%
0.00%
Q4 2019$1,000350.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders